account_balance
Investment manager · 13F filer · SEC CIK 1263508
Baker Bros. Advisors LP
Reported value$20Bas of Jun 30, 2026
Positions84 8 new, 8 sold out
Top 10 weight72.8%INCY alone is 17%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
INCYIncyte Corporation
17.5%
ONCBeOne Medicines Ltd.
12.6%
RVMDRevolution Medicines, Inc.
10.7%Added +20%
MDGLMadrigal Pharmaceuticals, Inc.
5.8%
ACADAcadia Pharmaceuticals Inc.
5.4%
KYMRKymera Therapeutics, Inc.
5.0%
INSMInsmed Incorporated
4.7%Added +19%
CELCCelcuity Inc.
4.2%
KODKodiak Sciences Inc.
3.9%
RYTM3.1%PRAXPraxis Precision Medicines, Inc.
2.9%
ALKSAlkermes PLC
2.6%
INCYIncyte Corporation
17.5%
ONCBeOne Medicines Ltd.
12.6%
RVMD10.7%MDGL5.8%ACAD5.4%KYMR5.0%INSM4.7%CELC4.2%KOD3.9%RYTM3.1%PRAX2.9%ALKS2.6%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
INCY Incyte Corporation 17.5% HeldONC BeOne Medicines Ltd. 12.6% HeldRVMD Revolution Medicines, Inc. 10.7% Added +20%MDGL Madrigal Pharmaceuticals, Inc. 5.8% HeldACAD Acadia Pharmaceuticals Inc. 5.4% HeldKYMR Kymera Therapeutics, Inc. 5.0% HeldINSM Insmed Incorporated 4.7% Added +19%CELC Celcuity Inc. 4.2% HeldKOD Kodiak Sciences Inc. 3.9% HeldRYTM Rhythm Pharmaceuticals, Inc. 3.1% HeldPRAX Praxis Precision Medicines, Inc. 2.9% HeldALKS Alkermes PLC 2.6% Held
What changed